Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Philip S. Bennett"'
Autor:
Scott L. Barmat, Jean-Luc Bodmer, Irina V. Gates, Yuhua Zhang, Christopher J. Wang, Diana Pacchione, Tina Frey, Daniel B. Joelsson, Luca Benetti, Philip S. Bennett, Heather Baxter, Kristin C. Brodbeck, Jennifer L. McMackin
Publikováno v:
Journal of Virological Methods. 166:1-11
Vaccine manufacturing requires constant analytical monitoring to ensure reliable quality and a consistent safety profile of the final product. Concentration and bioactivity of active components of the vaccine are key attributes routinely evaluated th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a39de80ae856de353301ba6760e5b7cf
https://doi.org/10.1016/j.jviromet.2010.01.016
https://doi.org/10.1016/j.jviromet.2010.01.016
Publikováno v:
Journal of Agricultural, Biological, and Environmental Statistics. 10:148-157
A house standard lot is tested along with experimental samples in a variable TCID50 assay in order to monitor and control assay performance. Instead of being simply a control, it is proposed to use this lot as a calibration standard to reduce the sys
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6deeaa86ba94cc3f966b9a03e9945bc7
https://doi.org/10.1198/108571105x48217
https://doi.org/10.1198/108571105x48217
Autor:
Luca Benetti, Philip S. Bennett, John I. Haynes, Christopher J. Wang, Jennifer Naspinski, Pulkit S. Bose, Girish Kartha
Publikováno v:
Journal of virological methods. 167(2)
Rubella virus (RV, German measles) is a teratogenic agent that can lead to serious congenital defects after maternal infection during early pregnancy. Currently, the disease can be prevented effectively by available live attenuated vaccines. An impor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38cc6dc56813aa570fd08b05a86e5311
https://pubmed.ncbi.nlm.nih.gov/20399228
https://pubmed.ncbi.nlm.nih.gov/20399228
Autor:
Mary-Ellen Davies, Paul M. Keller, Mark D. Yeager, Danilo R. Casimiro, Nancy M. Dougherty, Laura L. Franlin, John W. Shiver, Elayne C. Dell, Andrew J. Bett, Philip S. Bennett, Helen C. Perry, Fubao Wang, Miguel Aste-Amezaga, Joseph M. Antonello, Deepa K. Patel
Publikováno v:
Human gene therapy. 15(3)
Replication-defective recombinant adenoviruses (rAd) are used as vectors for vaccines as well as for gene therapy. To determine type-specific antibodies to adenovirus (Ad) serotypes 2, 5, 24, 34, and 35, we developed quantitative neutralization assay
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11a76d06911397110a79b8bc271080de
https://pubmed.ncbi.nlm.nih.gov/15018738
https://pubmed.ncbi.nlm.nih.gov/15018738
Autor:
Miguel Aste-Amézaga, Andrew J. Bett, Fubao Wang, Danilo R. Casimiro, Joseph M. Antonello, Deepa K. Patel, Elayne C. Dell, Laura L. Franlin, Nancy M. Dougherty, Philip S. Bennett, Helen C. Perry, Mary-Ellen Davies, John W. Shiver, Paul M. Keller, Mark D. Yeager
Publikováno v:
Human Gene Therapy; 3/01/2004, Vol. 15 Issue 3, p293-304, 12p